Skip to main content
main-content
Top

26-04-2018 | Ankylosing spondylitis | Article

Tofacitinib is associated with attainment of the minimally important reduction in axial magnetic resonance imaging inflammation in ankylosing spondylitis patients

Maksymowych WP et al. Rheumatology (Oxford) 2018; Advance online publication. doi: 10.1093/rheumatology/key104

Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.

https://doi.org/10.1093/rheumatology/key104

Related topics